BCL2 and laryngeal carcinoma: Similar findings showed that laryngeal cancer cells (Hep-2) treated with synthesized ZnO-NPs from Marsdenia Tenacissima expressed a higher Bax and a lower Bcl-2 level of mRNA 51, 52.